Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
REGENECYTE
BIOLOGICAL
2 trials
Sponsors
StemCyte, Inc.
Conditions
Long COVID
Post COVID-19 Condition
Post-COVID Condition
Post-COVID Syndrome
Post-COVID-19 Condition
Phase 2
Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome
Completed
NCT05682560
StemCyte, Inc.
Long COVID, Post COVID-19 Condition, Post-COVID Syndrome
Start: 2023-05-04
End: 2025-02-27
Updated: 2025-03-24
Phase 3
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
Not yet recruiting
NCT07184385
StemCyte, Inc.
Long COVID, Post-COVID-19 Condition, Post-COVID Condition +1
Start: 2026-03-31
End: 2027-09-30
Target: 60
Updated: 2025-09-23